Business Description
Co-Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US1897631057
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.38 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.07 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.1 | |||||
Beneish M-Score | -3.75 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55.7 | |||||
3-Year Book Growth Rate | 5.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.44 | |||||
9-Day RSI | 58.65 | |||||
14-Day RSI | 53.94 | |||||
6-1 Month Momentum % | 9.84 | |||||
12-1 Month Momentum % | 27.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.09 | |||||
Quick Ratio | 8.81 | |||||
Cash Ratio | 8.46 | |||||
Days Inventory | 276.21 | |||||
Days Sales Outstanding | 26.14 | |||||
Days Payable | 169.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -3.08 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.86 | |||||
Operating Margin % | -433.76 | |||||
Net Margin % | -421.08 | |||||
FCF Margin % | -285.15 | |||||
ROE % | -42.72 | |||||
ROA % | -38.8 | |||||
ROIC % | -108.62 | |||||
ROC (Joel Greenblatt) % | -566.55 | |||||
ROCE % | -42.28 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.33 | |||||
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 0.9 | |||||
EV-to-EBIT | 0.04 | |||||
EV-to-EBITDA | 0.04 | |||||
EV-to-Revenue | -0.16 | |||||
EV-to-Forward-Revenue | 0.31 | |||||
EV-to-FCF | 0.01 | |||||
Price-to-Projected-FCF | 0.41 | |||||
Price-to-Net-Current-Asset-Value | 1.07 | |||||
Price-to-Net-Cash | 1.17 | |||||
Earnings Yield (Greenblatt) % | 2500 | |||||
FCF Yield % | -61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CODX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Co-Diagnostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 8.922 | ||
EPS (TTM) ($) | -1.26 | ||
Beta | 1.33 | ||
Volatility % | 39.33 | ||
14-Day RSI | 53.94 | ||
14-Day ATR ($) | 0.105388 | ||
20-Day SMA ($) | 1.24768 | ||
12-1 Month Momentum % | 27.62 | ||
52-Week Range ($) | 1 - 2.2299 | ||
Shares Outstanding (Mil) | 31.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Co-Diagnostics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Co-Diagnostics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Co-Diagnostics Inc Frequently Asked Questions
What is Co-Diagnostics Inc(CODX)'s stock price today?
When is next earnings date of Co-Diagnostics Inc(CODX)?
Does Co-Diagnostics Inc(CODX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |